Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI heart test could speed up lifesaving device implants

NCT ID NCT07217236

Recruiting now Diagnosis Sponsor: National Defense Medical Center, Taiwan Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial is testing whether an artificial intelligence-enhanced electrocardiogram (AI-ECG) can better identify patients who need a cardiac implantable electronic device (like a pacemaker or defibrillator) compared to standard care. Over 11,000 participants will be randomly assigned to either the AI-ECG strategy or usual care. Those flagged as high-risk by the AI will receive a continuous heart monitor for up to 7 days. The goal is to see if the AI approach leads to more timely and appropriate device implantation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

AI-enhanced electrocardiogram (ECG) with continuous cardiac rhythm monitoring

What this could lead to

If successful, this AI strategy could help doctors more quickly and accurately identify patients who need a pacemaker or defibrillator, potentially preventing serious heart complications.

What could go wrong

This is a large but early-stage trial, and the AI may not prove better than standard care. There is also a risk of false positives leading to unnecessary procedures or false negatives missing patients who need treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTIFICIAL INTELLIGENCE (AI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Arrhythmias, Cardiac conduction system disorder heart conduction disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARTIFICIAL INTELLIGENCE (AI) CARDIAC IMPLANTABLE ELECTRICAL DEVICES CONDUCTION DISORDER OF THE HEART

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Tri-Service General Hospital

    RECRUITING

    Taipei, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••